内部人交易记录
董事尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Ho Maykin, 董事. Officer active across 5 companies, notably Biomarin Pharmaceutical INC. In total, 16 reports have been logged. History available since 25 May 2021. The latest transaction was disclosed on 2 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Ho Maykin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报16 总计
2,816 股Common stockSEC:0001439222-26-000099:0
7,490 股0Common StockSEC:0001628280-26-040918:0
2,120 股0Common stockSEC:0001439222-25-000053:0
6,650 股0Common StockSEC:0001048477-25-000072:0
3,388 股0Common stockSEC:0001439222-24-000081:0
20,100 股0Common StockSEC:0001610717-24-000338:0
4,720 股0Common StockSEC:0001048477-24-000104:0
4,975 股0Common stockSEC:0001439222-23-000095:0
8,289 股0Common StockSEC:0001209191-23-036078:0
4,190 股0Common StockSEC:0001209191-23-031970:0
15,777 股0Common StockSEC:0001209191-22-038616:0
4,980 股0Common StockSEC:0001567619-22-011792:0
1,585 股0Common stockSEC:0001439222-22-000050:0
1,686 股0Common stockSEC:0001439222-21-000049:0
4,700 股0Common StockSEC:0001209191-21-036678:0
5,120 股0Common StockSEC:0001567619-21-011306:0
About Ho Maykin
Ho Maykin is Administrateur and has 16 filings in total. In the recent filings sampled from 2021-05-27 to 2026-06-23, the dominant transaction nature is Attribution, with sum_buy_eur at 0 and sum_sell_eur at 0.